Patents
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
06/2000
06/07/2000EP0840606B1 Di- and trivalent small molecule selectin inhibitors
06/07/2000EP0773025B1 New stable galenic formulations containing an acid-labile benzimidazol compound, and production process
06/07/2000EP0727994B1 Antipyretic and analgesic methods and compositions containing optically pure r-etodolac
06/07/2000EP0714304B1 Therapeutic system for treating psoriasis
06/07/2000EP0699197B1 4-p-fluorobenzoyl-1-piperidinyl-propoxy-chromen-4-one derivatives, their preparation and their use in the treatment of psychosis and schizophrenia
06/07/2000EP0633783B1 Rapamycin formulation for iv injection
06/07/2000CN1255924A New process for prepn. of pharmacologically active substance
06/07/2000CN1255923A 6-substituted 1,2,4a,51,8a,8b hexahydro- and 1,2,3,4,4a,5a,8a,8b-octahydro-6h-pyrrolo [3',4': 4,5] furo [3,2-b] pyrid-8(7h)-on derivatives and their use in combatting encoparasites
06/07/2000CN1255919A Efficient enantioselective addition reaction using organozinc reagent
06/07/2000CN1255917A Anti-convulsant isoquinolyl-benzamide derivatives
06/07/2000CN1255864A Combination of ileal bile acid transport inhibiting benzothiepines and HMG Co-A reductase inhibitors
06/07/2000CN1255859A Pharmaceutical antiviral compsn. comprising glycyrrhizic acid and at least one protein endowed with antiviral activity
06/07/2000CN1255855A Fructan containing compsn. for prevention and treatment of colon cancer
06/07/2000CN1255854A Use of 1,2,4-triazolo [1,5-C] pyrimidine heterocyclic analogues for prepn. of medicaments useful for treatment of cerebrovascular disturbances
06/07/2000CN1255853A Medical compsns. against helicobacter pylori
06/07/2000CN1255852A Novel method and compsns. for drug feeding of taxad alkyl compounds
06/07/2000CN1255850A Topical compsns.
06/07/2000CN1255849A Medical compsns.
06/07/2000CN1255848A Process for making flurbiprofen lozenges
06/07/2000CN1255829A Stable ascorbic acid inorganic salt liquid compsns., its prepn. method and applications
06/07/2000CN1255540A Process for preparing biologic preparation containing linolenic acid
06/07/2000CN1255501A Novel phosphonyl sulfonic ester compound and its medicinal compsns.
06/07/2000CN1255497A Method for preparing pyrazo [4,3-d] pyrimidine-7-one and its intermediate
06/07/2000CN1255494A Polyacetyl acetogenins for eliminating HIV virus and treating AIDS
06/07/2000CN1255493A Novel dihydro and tetrahydro chinoline compounds, its prepn. method and medicinal compsns.
06/07/2000CN1255379A Identification method of compound for inhibiting tumour injury and medicinal compsns. containing said compound
06/07/2000CN1255376A Method of enhancing crude drugs anti-tumour activity
06/07/2000CN1255374A Medicine for curing diseases in nerve system and its preparing process
06/07/2000CN1255373A Medicine for treating multiple skin diseases and its preparing process
06/07/2000CN1255367A Compsns. for recovering and promoting skin protective functions and its evaluating method
06/07/2000CN1255357A Grape seed extract with strong anti-tyrosine enzyme activity and its application
06/07/2000CN1255351A Decrustation ointment for burn and its preparing process
06/07/2000CN1255349A Compound Chinese medicine for treating diabetes
06/07/2000CN1255348A Medicine for treating gynopathy
06/07/2000CN1255337A Medicine for treating hydrocephalus
06/07/2000CN1255334A Ointment for treating face mite disease
06/07/2000CN1255333A Medical application of aquatic-sunflower lactone
06/07/2000CN1255332A Release-controlled micropill for treating benign prostatic hyperplasis and its preparing process
06/07/2000CN1053194C Process for preparing n-acyl-5-fluorocytidine derivatives
06/07/2000CN1053193C Esculetin derivatives, process for manufacture and use thereof, and pharmaceutical compsn.
06/07/2000CN1053190C Quinoxalindione derivs, their prepn. and their used in drugs
06/07/2000CN1053189C Pyridazino qujinoline compounds
06/07/2000CN1053188C Quinolizinone type compounds
06/07/2000CN1053187C Derivatives of benzoylecgonine, ecgonine and ecgonidine and methods for preparing and using same
06/07/2000CN1053184C Novel aconitine-like compound and antipyretic analgesic anti-inflammatory agent
06/07/2000CN1053182C Novel 9-amino-7-substituted-6-demethyl-6-deoxytetracyclines, its prepn. process and compsns. thereof
06/07/2000CN1053114C Medicine for curing bilestone and biliary calculus
06/07/2000CN1053103C Pharmaceutical use of 24-homo-vitamin-D-derivative
06/07/2000CN1053102C Application of benzothiophene derivative for medicines of inhibiting cartilage degradation
06/06/2000US6072068 Treating glucocorticoid-dependent diseases or symptoms
06/06/2000US6072062 Synthesis of C18 -modified vitamin D compounds and compounds resulting therefrom
06/06/2000US6072051 Viricide against hepatitis b virus with low toxicity
06/06/2000US6072045 Chimeric isoprenoid synthases and uses thereof
06/06/2000US6072032 Amino acid sequence of polypeptide involved in protein secretory apparatus of bacteria; for screening for bactericides and bacteriostats; diagnosis of and prophylaxis for infections
06/06/2000US6071974 Limpid parenteral solution of 2,6-diisoprophylphenol as an anaesthetic drug and 2.5-di-O-methyl-1.4;3.6-dianhydro-D-glucitol as a solvent for making clear I. V. formulation
06/06/2000US6071972 Useful for disinfecting or sterilizing medical devices or environmental surfaces
06/06/2000US6071971 For treating pulmonary disorders
06/06/2000US6071970 Compounds active at a novel site on receptor-operated calcium channels useful for treatment of neurological disorders and diseases
06/06/2000US6071969 Substituted aminoguanidines and methods of use thereof
06/06/2000US6071968 Phenylenediamine derivative radical scavenger, brain-infarction depressant, and brain-edema depressant
06/06/2000US6071966 1-amino-alkylcyclohexane NMDA receptor antagonists
06/06/2000US6071965 Phosphinic alkanoic acid derivatives
06/06/2000US6071964 Decreased gastrointestinal irritation, increased bioavailability
06/06/2000US6071963 Water dispersible compositions
06/06/2000US6071962 Oxa acids and related compounds for treating skin conditions
06/06/2000US6071961 For treating gastritis caused by caphylobacteria by administeing microbiocide comprising aliphatic or aromatic fatty acid, hydrotope and compatible acid
06/06/2000US6071960 For treatment of diseases caused by or resulting in metabolic dysfunction and/or energy deprivation, such as diabetes, acute starvation, endotoxemia, sepsis, systemic inflammatory response syndrome and multiple orgen dysfunction syndrome
06/06/2000US6071959 For relieving pain of lower gastrointestinal tract by rectal or oral administration of a complex of amide-type local anaesthetic and polyacrylate with carrier, diluent and/or excipient
06/06/2000US6071957 Irreversible non-steroidal antagonist compound and its use in the treatment of prostate cancer
06/06/2000US6071956 Treatment of tissues to reduce subsequent response to injury
06/06/2000US6071955 Treating terrestrial mammalian subject suffering from a conditions of acne and acneiform conditions by administering 7-methyl-9-(3,3-dimethyloxiranyl)-3-methyl-2,6-nonadienoic acid methyl ester
06/06/2000US6071953 For treating or preventing cardiovascular or gastrointestinal disorders, potassium channel modulators
06/06/2000US6071952 Stabilized injectable pharmaceutical compositions containing taxoid anti-neoplastic agents
06/06/2000US6071949 For treatment of cancers derived from epithelial cells
06/06/2000US6071948 Treatment of diseases caused by excessive blood vessel growth
06/06/2000US6071947 Indolyl-pyrrolydenemethylpyrrole derivatives and process for their preparation
06/06/2000US6071945 8H-thieno-[2,3-b]pyrrolizin-8-one compounds
06/06/2000US6071944 Method of treatment of pigmented cancer cells utilizing photodynamic therapy
06/06/2000US6071942 Elevation of circulating blood histamine levels
06/06/2000US6071939 Synergistic mixtures of a calcium antagonist and an angiotensin-ll-antagonist for treatment of cardiovascular disorders
06/06/2000US6071938 Benzopyrans
06/06/2000US6071936 Substituted pyridines as selective cyclooxygenase-2 inhibitors
06/06/2000US6071935 Derivatives of 2-(2-oxo-ethylidene)-imidazolidin-4-one and their use as farnesyl protein transferase inhibitors
06/06/2000US6071934 Indenyl hydroxamic acids, (hydroxy) ureas and urethanes for treating patients with precancerous lesions
06/06/2000US6071933 Homogeneous remifentanil-propofol blend for patient controlled anesthesia and process for its use
06/06/2000US6071932 Carbazolypiperines as GABA uptake inhibitors
06/06/2000US6071931 AT1 -receptor antagonists for preventing and treating postischemic renal failure and for protecting ischemic kidneys
06/06/2000US6071930 Method for treating tumors using 2-aryl-naphthyridin-4-ones
06/06/2000US6071929 Selective blockers of n-methyl-d-aspartic acid for teatment of nervous system and brain disorders or injuries
06/06/2000US6071928 Spiro-piperidine derivatives and their use as therapeutic agents
06/06/2000US6071927 Tachykinnin antagonists for the treatment or prevention of pain, inflammation, migraine, emesis and postherpetic neuralgia
06/06/2000US6071926 Sleep quality improvement using a growth hormone secretagogue
06/06/2000US6071925 Antidepressants, anticonvulsants or antianxiety agents, also for treatment of memory loss in alzheimer's disease
06/06/2000US6071924 Method of preventing proliferation of retinal pigment epithelium by retinoic acid receptor agonists
06/06/2000US6071923 Retinoyloxy aryl-substituted alkylene butyrates useful for the treatment of cancer and other proliferative diseases
06/06/2000US6071921 4-phenyl-7-arylquinoazolines; angiogenisis inhibitors and/or vascular permeability reducing effects in warm-blooded animals; anticarcinogenic and -arthritic agents; rheumatic diseases; vascular endothelium growth factor inhibitors
06/06/2000US6071920 Bind to 5ht 1a receptors for treating disorders of the lower urinary tract; cns disorders; anxiolytic agents; antidepressants; hypotensive agents; sleep and eating disorders
06/06/2000US6071919 Stimulate the immunological system and to induce the production of hypercellular bone marrow and extramedullary hematopoiesis; antitumor and -carcinogenic agents; autoimmune diseases; viricides; hepatitis
06/06/2000US6071918 A synergistic combination of at least one opioid antagonist, naltrexone, nalmefene; and at least one selective serotonin reuptake inhibitor paroxetine; side effect reduction
06/06/2000US6071915 Arylsubstituted piperazines useful in the treatment of benign prostatic hyperplasia